z-logo
open-access-imgOpen Access
Elevated Cystatin-C Levels Are Associated with Increased Mortality in Acute Coronary Syndrome Patients: An HIJ-PROPER Sub-Analysis
Author(s) -
Saito Takashi,
Arashi Hiroyuki,
Yamaguchi Junichi,
Mori Fumiaki,
Ogawa Hiroshi,
Hagiwara Nobuhisa
Publication year - 2022
Publication title -
cardiorenal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 21
eISSN - 1664-5502
pISSN - 1664-3828
DOI - 10.1159/000522412
Subject(s) - research article
Background and Aims: We investigated the association between serum cystatin-C (Cys-C) levels and cardiovascular events in patients with acute coronary syndrome (ACS). Methods: Data of 1,100 patients from the prospective parent study were included. Patients hospitalized for ACS were divided into 4 groups based on quartiles (Q) of Cys-C levels (mg/L) within 24 h of admission: Q1, ≤0.82; Q2, 0.82 < estimated level ≤0.95; Q3, 0.95< estimated level ≤1.12; and Q4, >1.12. The primary endpoint of this study was all-cause mortality, and the secondary endpoint was composite of all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, unstable angina pectoris, or ischemia-driven revascularization. Results: During a median observation period of 4.0 years, the primary endpoint was noted in 5, 12, 18, and 36 patients in Q1–Q4, respectively, with corresponding incidence rates of 1.8%, 4.4%, 6.5%, and 13.5%, respectively ( p < 0.0001 for difference among 4 groups). This association persisted even after adjusting for patient characteristics and other laboratory results at baseline ( p = 0.04). A stepwise increase in the incidence rate of the secondary endpoint with an incline in Cys-C levels was observed in the nonadjusted model (26.6%, 33.3%, 32.3%, and 39.1% in Q1–Q4, respectively; p = 0.01) but not in the adjusted model ( p = 0.3). No difference was observed in the incidence rate of nonfatal myocardial infarction ( p = 0.89), nonfatal stroke ( p = 0.3), unstable angina pectoris ( p = 0.49), and ischemia-driven revascularization ( p = 0.47) with an incline in Cys-C levels. Conclusion: Elevated Cys-C levels were associated with increased all-cause mortality but not cardiovascular events other than mortality in ACS patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here